Track VivoSim Labs's receivables ($29K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), VIVS shows a receivables of $29K. That compares with $32K in the prior-year period — down 9.4% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, VIVS's receivables is now $29K (was $32K) — a 9.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether VivoSim Labs is outperforming or lagging.
Tracking VIVS's receivables over time shows whether VivoSim Labs is scaling, shrinking, or reshaping that part of the business. The current reading is $29K That compares with $32K in the prior-year period — down 9.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this receivables page, Stockcircle has VivoSim Labs's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $29K) with ownership activity and broader fundamentals.
VivoSim Labs's receivables is $29K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.